Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Ryota Tamura, Masato Fujioka, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida, Masahiro Toda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29a3a63b717e403f85dd2fc3876d3939 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Ryota Tamura, et al.
Publicado: (2019) -
Potential use of Sr isotope ratio to evaluate trace metal uptake in moss
por: Yoshitaka Oishi
Publicado: (2021) -
Segmental neurofibromatosis presenting with congenital excessive skin folds
por: Alexander M. Helfand, et al.
Publicado: (2015) -
Alterations in brain morphology by MRI in adults with neurofibromatosis 1
por: Su Wang, et al.
Publicado: (2021) -
Dietary patterns of Brazilian adults with neurofibromatosis type 1
por: Vilela,Darlene Larissa de Souza, et al.
Publicado: (2020)